The most frequently diagnosed disease in men and the second leading cause of cancer death in the US is prostate cancer (PCa). Although localised PCa is becoming less common among American males, it still has a considerable morbidity and mortality rate. We set out to research the variables that might affect how patients and doctors choose their courses of therapy. More precisely, we looked into how different demographic groups in the United States used RP, RT, and AS therapy choices differently to treat localised PCa, paying close attention to the impact of population density. and facility type for cancer centres. The standard of care is not as clearly defined as it is for other malignancies, but many considerations (such as availability, accessibility, and preference) may play a role in selecting a therapeutic choice.
In order to improve patient outcomes, we seek to raise awareness of the complexity of the treatment choices in PCa by exposing these variations in care based on demographics.
Author (s) Details
Christian S. DiBiase
Boston College, United States.
Baoqing Li
Weill Cornell Medicine College, United
States.
View Book :- https://stm.bookpi.org/CPMS-V6/article/view/7677
No comments:
Post a Comment